Abstract
Chronic hypoxia (CH) activates the Ca(2+)-dependent transcription factor nuclear factor of activated T cells isoform c3 (NFATc3) in mouse pulmonary arteries. However, the mechanism of this response has not been explored. Since we have demonstrated that NFATc3 is required for CH-induced pulmonary arterial remodeling, establishing how CH activates NFATc3 is physiologically significant. The goal of this study was to test the hypothesis that endothelin-1 (ET-1) contributes to CH-induced NFATc3 activation. We propose that this mechanism requires increased pulmonary arterial smooth muscle cell (PASMC) intracellular Ca(2+) concentration ([Ca(2+)](i)) and stimulation of RhoA/Rho kinase (ROK), leading to calcineurin activation and actin cytoskeleton polymerization, respectively. We found that: 1) CH increases pulmonary arterial pre-pro-ET-1 mRNA expression and lung RhoA activity; 2) inhibition of ET receptors, calcineurin, L-type Ca(2+) channels, and ROK blunts CH-induced NFATc3 activation in isolated intrapulmonary arteries from NFAT-luciferase reporter mice; and 3) both ET-1-induced NFATc3 activation in isolated mouse pulmonary arteries ex vivo and ET-1-induced NFATc3-green fluorescence protein nuclear import in human PASMC depend on ROK and actin polymerization. This study suggests that CH increases ET-1 expression, thereby elevating PASMC [Ca(2+)](i) and RhoA/ROK activity. As previously demonstrated, elevated [Ca(2+)](i) is required to activate calcineurin, which dephosphorylates NFATc3, allowing its nuclear import. Here, we demonstrate that ROK increases actin polymerization, thus providing structural support for NFATc3 nuclear transport.
Publication types
-
Research Support, American Recovery and Reinvestment Act
-
Research Support, N.I.H., Extramural
MeSH terms
-
Actins / metabolism
-
Active Transport, Cell Nucleus
-
Animals
-
Calcineurin / metabolism
-
Calcineurin Inhibitors
-
Calcium Channels, L-Type / drug effects
-
Calcium Channels, L-Type / metabolism
-
Calcium Signaling
-
Cells, Cultured
-
Chronic Disease
-
Cytoskeleton / metabolism
-
Disease Models, Animal
-
Endothelin Receptor Antagonists
-
Endothelin-1 / antagonists & inhibitors
-
Endothelin-1 / genetics
-
Endothelin-1 / metabolism*
-
Genes, Reporter
-
Humans
-
Hypoxia / genetics
-
Hypoxia / metabolism*
-
Male
-
Membrane Transport Modulators / pharmacology
-
Mice
-
Mice, Inbred BALB C
-
Mice, Knockout
-
Muscle, Smooth, Vascular / drug effects
-
Muscle, Smooth, Vascular / metabolism*
-
Myocytes, Smooth Muscle / drug effects
-
Myocytes, Smooth Muscle / metabolism*
-
NFATC Transcription Factors / genetics
-
NFATC Transcription Factors / metabolism*
-
Phosphorylation
-
Protein Kinase Inhibitors / pharmacology
-
Pulmonary Artery / drug effects
-
Pulmonary Artery / metabolism*
-
RNA, Messenger / metabolism
-
Receptors, Endothelin / metabolism
-
Recombinant Fusion Proteins / metabolism
-
Time Factors
-
Transcriptional Activation
-
Transfection
-
Up-Regulation
-
rho GTP-Binding Proteins / metabolism
-
rho-Associated Kinases / antagonists & inhibitors
-
rho-Associated Kinases / metabolism
-
rhoA GTP-Binding Protein
Substances
-
Actins
-
Calcineurin Inhibitors
-
Calcium Channels, L-Type
-
Endothelin Receptor Antagonists
-
Endothelin-1
-
Membrane Transport Modulators
-
NFATC Transcription Factors
-
Nfatc3 protein, mouse
-
Protein Kinase Inhibitors
-
RNA, Messenger
-
Receptors, Endothelin
-
Recombinant Fusion Proteins
-
rho-Associated Kinases
-
Calcineurin
-
RhoA protein, mouse
-
rho GTP-Binding Proteins
-
rhoA GTP-Binding Protein